Charles Casamento

Charles J.
Casamento was the founder of Indevus Pharmaceuticals, Inc., founded in 1989, where the title held was President & Chief Executive Officer from 1989 to 1993.
Mr. Casamento was the founder of Questcor Pharmaceuticals, Inc., founded in 1999, where the title held was Chairman, President & Chief Executive Officer from 1999 to 2004.
Current jobs include Chairman at Relmada Therapeutics, Inc. since 2017, Independent Director at GT Biopharma, Inc. since 2023, Director at KineMed, Inc. since 2013, Executive Director at Sage Healthcare Ltd. since 2014, Independent Director at Astex Pharmaceuticals, Inc. since 2002, Executive Director & Principal at The Sage Group LLC (Washington) since 2007, Director at PaxMedica, Inc., and Member-Science Council at Fordham University.
Former jobs include Chairman, President & Chief Executive Officer at RiboGene, Inc. from 1993 to 1999; President & Chief Executive Officer at Osteologix, Inc. from 2004 to 2007; Chairman at RespireRx Pharmaceuticals, Inc. from 2012 to 2013; Vice Chairman at Catholic Medical Mission Board, Inc.; Director at SuperGen, Inc. from 2002 to 2011; Independent Director at VIVUS, Inc. from 2011 to 2013; Independent Director at International Stem Cell Corp.
from 2011 to 2019; Director at Mount Saint Michael Academy, Inc.; Independent Director at GridAI Technologies Corp.
from 2017 to 2024; Lead Independent Director at PaxMedica, Inc. from 2023 to 2025; VP-Business Development & Strategic Planning at Johnson & Johnson; Senior VP-Pharmaceuticals & Biochemicals at Genzyme Corp.
from 1985 to 1989; VP-Business Development & Strategic Planning at Sandoz, Inc.; VP-Business Development & Strategic Planning at Hoffmann-La Roche, Inc.; VP-Business Development & Strategic Planning at American Hospital Supply Corp.
from 1983 to 1985.
Education includes an undergraduate degree from Fordham University conferred in 1968 and an MBA from Iona College conferred in 1971.